Dermapharm Holding SE (DMPHF)
DMPHF Stock Price Chart
Explore Dermapharm Holding SE interactive price chart. Choose custom timeframes to analyze DMPHF price movements and trends.
DMPHF Company Profile
Discover essential business fundamentals and corporate details for Dermapharm Holding SE (DMPHF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
29 Nov 2022
Employees
3.61K
Website
https://www.dermapharm.deCEO
Hans-Georg Feldmeier
Description
Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription natural remedies, and other healthcare products. It also offers healthcare products in the areas of vitamins, minerals, food supplements, dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology primarily under the Dekristol, Dekristolvit, Allergovit, and Tromcardin brands. In addition, the company provides medical devices under the bite away and Herpotherm names; Momekort, a nasal spray used to treat allergy symptoms; and Azedil, a nasal spray or eye drop. Further, it imports originator pharmaceuticals under the axicorp brand; and offers herbal extracts and natural active ingredients for phytopharmaceuticals, nutraceuticals, and cosmetics. It serves pharmaceutical wholesalers, pharmacies, hospitals, and health food stores. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-Aktiengesellschaft.
DMPHF Financial Timeline
Browse a chronological timeline of Dermapharm Holding SE corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 26 Mar 2026
Upcoming earnings on 13 Nov 2025
Earnings released on 26 Aug 2025
EPS came in at $0.46 , while revenue for the quarter reached $320.53M , meeting expectations.
Dividend declared on 27 Jun 2025
A dividend of $1.06 per share was announced, adjusted to $1.05. The dividend was paid on 1 Jul 2025.
Earnings released on 15 May 2025
EPS came in at $0.68 , while revenue for the quarter reached $331.50M .
Earnings released on 14 Mar 2025
EPS came in at $0.39 , while revenue for the quarter reached $300.99M , missing expectations by -1.51%.
Earnings released on 14 Nov 2024
EPS came in at $0.66 , while revenue for the quarter reached $341.74M , beating expectations by +3.59%.
Earnings released on 14 Aug 2024
EPS came in at $0.34 , while revenue for the quarter reached $305.16M , beating expectations by +1.82%.
Dividend declared on 28 Jun 2024
A dividend of $0.94 per share was announced, adjusted to $0.94. The dividend was paid on 2 Jul 2024.
Earnings released on 15 May 2024
EPS came in at $0.87 , while revenue for the quarter reached $323.81M .
Earnings released on 7 Mar 2024
EPS came in at -$0.05 , while revenue for the quarter reached $301.49M .
Earnings released on 30 Sept 2023
EPS came in at $0.49 , while revenue for the quarter reached $300.07M .
Earnings released on 30 Jun 2023
EPS came in at -$0.19 , while revenue for the quarter reached $286.88M , beating expectations by +0.04%.
Dividend declared on 15 Jun 2023
A dividend of $1.15 per share was announced, adjusted to $1.15. The dividend was paid on 19 Jun 2023.
Earnings released on 31 Mar 2023
EPS came in at $1.00 , while revenue for the quarter reached $346.95M , beating expectations by +3.60%.
Earnings released on 28 Mar 2023
EPS came in at $0.60 , while revenue for the quarter reached $312.94M , beating expectations by +0.51%.
Earnings released on 16 Nov 2022
EPS came in at $0.96 surpassing the estimated $0.93 by +3.33%, while revenue for the quarter reached $256.97M , missing expectations by -0.60%.
Earnings released on 31 Aug 2022
EPS came in at $0.27 falling short of the estimated $0.76 by -64.24%, while revenue for the quarter reached $250.50M , missing expectations by -0.07%.
Dividend declared on 2 Jun 2022
A dividend of $2.33 per share was announced, adjusted to $2.33. The dividend was paid on 6 Jun 2022.
Earnings released on 18 May 2022
EPS came in at $0.69 , while revenue for the quarter reached $256.22M .
Earnings released on 12 Apr 2022
EPS came in at $1.51 matching the estimated $1.51, while revenue for the quarter reached $309.18M , missing expectations by -0.27%.
Earnings released on 16 Nov 2021
EPS came in at $1.15 surpassing the estimated $0.98 by +17.35%, while revenue for the quarter reached $281.40M .
Earnings released on 7 Sept 2021
EPS came in at $0.74 , while revenue for the quarter reached $255.72M .
Dividend declared on 24 Jun 2021
A dividend of $1.05 per share was announced, adjusted to $1.05. The dividend was paid on 28 Jun 2021.
Earnings released on 18 May 2021
EPS came in at $0.67 surpassing the estimated $0.59 by +13.56%, while revenue for the quarter reached $249.60M .
Earnings released on 30 Mar 2021
EPS came in at $0.56 surpassing the estimated $0.51 by +9.02%, while revenue for the quarter reached $265.70M .
Earnings released on 16 Nov 2020
EPS came in at $0.42 falling short of the estimated $0.43 by -2.33%, while revenue for the quarter reached $233.62M .
Earnings released on 9 Sept 2020
EPS came in at $0.22 falling short of the estimated $0.38 by -42.11%, while revenue for the quarter reached $208.98M .
DMPHF Stock Performance
Access detailed DMPHF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.